# Health Tech Communications & Marketing: The Complete 2026 Guide
Health tech is one of the fastest-growing sectors in the U.S. economy and one of the most communications-intensive. The companies reshaping clinical workflows, patient experience, and healthcare delivery operate inside a regulatory and trust environment that pure-play tech firms have never faced. The communications discipline required is correspondingly different.
This is the definitive guide to that discipline.
What Health Tech Communications Means in 2026
Health tech communications is the integrated practice of building credibility, demand, and reputation for digital health platforms, telehealth providers, medical device makers, health AI companies, EHR vendors, and the venture-backed startups bringing software discipline to clinical workflows. It combines media relations, KOL programs, regulatory communications, investor relations, analyst engagement, patient advocacy partnerships, and AI Communications into a single integrated capability.
The discipline is distinguished from generalist tech PR by the regulatory layer, the clinical credibility requirement, and the trust dynamics specific to healthcare. A consumer tech brand making aggressive claims faces FTC enforcement risk. A health tech brand making the same claims faces FDA warning letters, FTC enforcement, plaintiff litigation, physician backlash, and the credibility damage that ends companies in clinical markets where trust is the operative currency.
The firms that get this right treat communications as a core capability that integrates regulatory affairs, medical affairs, marketing, and investor relations rather than treating each function in isolation.
The Health Tech Landscape
Health tech spans multiple sub-sectors with distinct buyer audiences, regulatory environments, and competitive dynamics. Telehealth platforms (Teladoc, Amwell, Hims & Hers, Ro, plus a long tail of category-specific telehealth specialists). Remote patient monitoring and digital therapeutics. AI diagnostics and clinical decision support. Surgical robotics and connected medical devices. Electronic health records and clinical workflow software (Epic, Oracle Health, Athenahealth, eClinicalWorks). Revenue cycle management and healthcare administrative software. Patient engagement and experience platforms. Clinical trials infrastructure. Health data infrastructure and interoperability platforms.
Buyers include hospital systems and health system C-suites, payers and benefit consultants, employers selecting health benefits, ambulatory clinical practices, retail clinics, pharmacy chains, life sciences companies, and increasingly consumers paying out of pocket for telehealth, digital therapeutics, and direct-to-consumer health products.
Each sub-sector has its own buyer dynamics, sales cycle, regulatory environment, and competitive set. Communications strategy that does not differentiate creates messaging that lands nowhere convincingly.
Why Health Tech Communications Is Different from Generalist Tech PR
Health tech has structural characteristics that require specialized communications capability beyond what generalist tech PR firms provide.
The FDA regulates clinical claims, medical device classification, software as a medical device (SaMD), and increasingly AI-enabled clinical decision support. Communications teams that do not understand the difference between a wellness app and a Class II medical device, between marketing claims and clinical claims, will create exposure that ends companies.
HIPAA and the broader privacy environment shape every communication touching protected health information. Marketing materials, case studies, customer testimonials, and product communications all must navigate rules that consumer tech does not face.
CMS reimbursement decisions shape product viability for entire categories — digital therapeutics, remote patient monitoring, certain telehealth services. Communications strategy must engage with reimbursement dynamics in ways consumer tech communications never has to.
State medical board rules govern cross-state telehealth, specific clinical scope-of-practice questions, and specific advertising claims. Communications campaigns that work nationally without state-by-state review create regulatory exposure.
The trust dynamic is the most consequential difference. Healthcare consumers trust their physicians more than any brand. Earned third-party validation from physicians, KOLs, peer-reviewed publications, and patient communities matters more than any paid campaign. Communications strategy that does not center clinical credibility fails in healthcare markets in ways it does not fail in consumer markets.
The Media That Matter
Health tech has a tiered media ecosystem requiring distinct strategy.
Tier one general business and tech: Wall Street Journal Health desk, Bloomberg, Reuters, New York Times Health desk, CNBC, Axios. These outlets shape category narrative for institutional investors and broad public audiences.
Tier two health-specific business: STAT News, Modern Healthcare, Becker’s Hospital Review, Healthcare Dive, Fierce Healthcare, Fierce Biotech, Endpoints News, Medical Marketing Marketing & Media. These outlets are read by buyer audiences (health system executives, payers, clinical leaders) and produce coverage that compounds in AI engine citations because it is sub-sector specific and credibility-rich.
Tier three clinical and trade: New England Journal of Medicine, JAMA, Nature Medicine, Health Affairs (peer-reviewed and policy); MedCity News, MobiHealthNews, Healthcare IT News, HIStalk (digital health trade); American Journal of Managed Care (payer audience). Coverage in these outlets is a clinical credibility signal that paid placement cannot replicate.
Tier four creator and independent: Substack and YouTube physicians and clinical leaders building independent audiences; physician influencer networks across Instagram and TikTok; healthcare-specific podcasts (A16z Bio + Health, Second Opinion, The Healthcare Policy Podcast). Independent clinical voices increasingly carry more credibility with both patient and clinical audiences than mainstream coverage.
The strategy must allocate effort across tiers based on audience and outcome. A digital health startup pitching health systems needs tier two and tier three more than tier one. A consumer-facing telehealth brand needs tier four heavily.
Communications Challenges in Health Tech
The defining challenge in health tech communications is balancing claim aggressiveness with regulatory exposure. Brands that under-claim lose pipeline to competitors who over-claim. Brands that over-claim attract FDA warning letters, FTC enforcement, plaintiff litigation, and physician backlash. The discipline of finding the maximally aggressive claim that survives regulatory and clinical scrutiny is the daily work of health tech communications teams.
A second challenge is translating complex science to non-clinical audiences without dumbing it down to the point of regulatory exposure. Health tech communications must reach hospital procurement executives, employer benefits consultants, payer medical directors, individual clinicians, and end-user patients — all with different sophistication levels and different scrutiny requirements.
A third challenge is the multi-stakeholder buyer process. A digital health vendor selling to a health system navigates clinical leadership (chief medical officer, department chairs), procurement, IT, finance, and increasingly compliance and legal. Each stakeholder has different concerns and different content needs. The communications strategy must support sales materials, conference presence, peer-reviewed publication strategy, KOL development, and earned media for each stakeholder type.
A fourth challenge is reimbursement uncertainty. Categories that depend on CMS coverage decisions or commercial payer recognition can grow or contract dramatically based on coding and reimbursement changes. Communications strategy must adjust to reimbursement evolution.
Regulatory Environment for Communicators
The regulatory environment for health tech communicators is multi-layered.
The FDA regulates marketing of regulated medical products under specific frameworks for drugs, devices, biologics, and software as a medical device. Promotional material for prescription products must satisfy fair balance requirements, present efficacy and safety information appropriately, and undergo review processes specific to product classification. AI-enabled clinical software is increasingly subject to FDA premarket review and post-market surveillance.
The FTC regulates marketing claims for non-prescription health products and consumer-facing health tech. The agency has been active in enforcement against health claims considered deceptive, particularly in supplements, wellness products, and consumer health technology.
HIPAA shapes any communication involving protected health information. Patient testimonials, case studies, and customer success stories must navigate consent and de-identification requirements that consumer tech communications never face.
CMS shapes reimbursement and coverage communications for products dependent on Medicare or Medicaid payment. Coverage determinations, coding decisions, and reimbursement levels are themselves communications-relevant events.
State regulators including medical boards, attorneys general, and insurance commissioners create state-specific rules around telehealth practice, advertising claims, and specific product categories.
The communications playbook must integrate with regulatory affairs, medical affairs, and legal teams, with pre-built templates for major communication categories and clear review workflows that move materials quickly while maintaining compliance.
Earned Media Strategy in Health Tech
Earned media strategy in health tech requires sub-sector specificity. The buyer audience for digital therapeutics is different from the audience for surgical robotics, which is different from the audience for revenue cycle management.
For digital health and telehealth: priorities include MobiHealthNews, MedCity News, Fierce Healthcare, STAT News, Modern Healthcare, plus tier-one consumer coverage in WSJ, NYT, and CNBC. Substack physicians and YouTube clinical leaders are increasingly important for both clinical and consumer audiences.
For medical devices: priorities include trade press (MedCity News, Medical Design Medical Design & Outsourcing, MD+DI), peer-reviewed clinical journals appropriate to the device category, KOL
engagement at major clinical conferences, and analyst engagement with FDA and CMS-focused investment analysts.
For health AI and clinical decision support: priorities include STAT News, Endpoints News, the broader health tech press, and increasingly the AI-specific business press (The Information, Stratechery, The New York Times tech desk). Peer-reviewed publication of validation studies is critical for clinical credibility.
For health system software (EHR, RCM, workflow): priorities include Becker’s Hospital Review, Modern Healthcare, Healthcare IT News, HIStalk, plus health system C-suite-targeted thought leadership through industry events (HIMSS, HLTH, ViVE).
The strategy must also account for AI Communications. Procurement teams in health systems and large physician practices increasingly use AI engines to research vendors before scheduling formal demos. Health tech firms with weak AI visibility lose pipeline at the consideration stage.
KOL Programs and Clinical Credibility
KOL (key opinion leader) programs are a defining capability in health tech communications. The right KOL endorsement, peer-reviewed publication, conference presentation, or clinical advisory board participation generates credibility that paid marketing cannot replicate.
KOL programs operate inside specific compliance frameworks. Payments to physicians (consulting fees, advisory board honoraria, speaker fees) are reportable under the Sunshine Act and visible to regulators, patients, and competitors. Compliance review is required for the structure, payment, and disclosure of KOL relationships.
The KOL strategy includes identification of credentialed clinicians in the relevant specialty, structured engagement (advisory boards, speakers bureau, clinical advisory roles), peer-reviewed publication strategy, conference presentation planning, and ongoing relationship development. The agencies and in-house teams that excel at KOL strategy build durable category authority. The teams that handle KOL programs as one-off transactional engagements build little.
AI Communications and AI Visibility in Health Tech
AI Communications has become a strategic priority for health tech faster than for almost any sector except financial services. The reasons are specific.
Buyer research has migrated to AI engines across every major buyer audience. Health system procurement teams research vendors inside ChatGPT and Perplexity. Employer benefits consultants research solutions for clients inside AI engines. Patients researching telehealth, digital therapeutics, or specific clinical conditions ask AI engines first.
The regulatory environment around AI in health tech is also accelerating. The FDA’s framework for AI/ML-enabled medical devices is evolving. CMS coverage decisions for AI-enabled clinical decision support are being established. State-level AI in healthcare legislation is emerging. Communications teams need fluency in AI policy alongside AI tactics.
The AI visibility audit has become standard diagnostic. Health tech firms now systematically measure their presence inside the major AI engines for the queries their buyers actually run. The findings are usually striking — even strong-brand firms often have shockingly thin AI visibility. For more on AI Communications methodology, see the <u>AI Communications</u> pillar.
Crisis Exposure in Health Tech
Health tech crisis exposure is unusually broad. Categories include FDA warning letters and enforcement actions, clinical safety events, cybersecurity breaches involving protected health information (with both HIPAA and SEC disclosure obligations), reimbursement coverage withdrawals, regulator investigations of marketing claims, executive misconduct, and increasingly AI-related events (algorithmic bias findings, hallucination incidents, deepfake impersonation of clinical leaders).
The communications response in health tech must coordinate with regulatory affairs, medical affairs, legal, IT security, clinical operations, and customer success. The single-channel crisis response that might suffice in consumer tech does not work in health tech. For more on crisis response, see the <u>Crisis Communications</u> pillar.
The healthcare context means that crisis communications also must consider patient safety implications. Communications that delay patient-relevant information, even to allow legal review, can compound harm and create regulator and litigation exposure that early disclosure would have avoided.
What’s Driving the Sector Now
Several forces are reshaping health tech communications simultaneously.
Generative AI is the dominant story. Every major health system is piloting LLM-based ambient scribing, clinical summarization, and patient-facing chat. The regulatory framework has not caught up, and communications teams must navigate aggressive product positioning against incomplete regulatory clarity.
Reimbursement pressure is reshaping digital therapeutics. Several high-profile digital therapeutics companies have retrenched after CMS coverage decisions disappointed, forcing the category to reposition.
M&A activity is concentrating in revenue cycle management and AI-enabled diagnostics, generating ongoing M&A communications work and reshaping the competitive landscape.
Consumer health tech is contending with growing skepticism about engagement metrics versus actual clinical outcomes. The category is differentiating between brands with credible clinical evidence and brands relying on consumer marketing without clinical substantiation.
Health system financial pressure has tightened procurement processes, lengthened sales cycles, and elevated the importance of credibility and clinical evidence in vendor selection.
How Health Tech Agencies Are Repositioning
The health tech agency landscape has evolved alongside the sector. The leading firms now position as integrated capabilities combining traditional PR, regulatory communications, KOL programs, content marketing, digital, and AI Communications. Generalist tech PR firms that handle health tech as one practice area are losing ground to specialists.
The diligence questions for evaluating a health tech communications agency include track record in the specific sub-sector, regulatory fluency, KOL relationships in the relevant clinical specialty, peer-reviewed publication experience, conference and analyst engagement capability, and increasingly AI Communications methodology.
Building an Internal Health Tech Communications Function
Most health tech firms operate with a smaller internal communications team complemented by specialized agency partners. The functions typically built internally include investor relations (especially for public companies), regulatory communications (often inside regulatory affairs), employee communications, and core executive media relations. The functions typically sourced externally include sub-sector media relations at scale, KOL program management, peer-reviewed publication strategy, conference and analyst engagement, content production, and AI Communications.
The error mode is treating communications as a marketing-adjacent function rather than as integrated with regulatory affairs, medical affairs, and clinical operations. The firms that get this right treat communications as a horizontal capability spanning the organization.
Where to Start
For health tech communications leaders new to the integrated discipline:
Audit current state across earned media, KOL coverage, peer-reviewed publication, AI visibility, regulator relationships, and analyst coverage.
Fix the foundation including compliance-approved templates, KOL engagement frameworks, peer-reviewed publication pipeline, and crisis response protocols.
Build sub-sector earned media programs targeting the specific buyer audiences for the firm’s products.
Integrate AI Communications including visibility audits, source cultivation, schema implementation, and ongoing LLM output monitoring.
Set the measurement framework connecting communications activity to clinical credibility, pipeline generation, customer acquisition, and reimbursement support.
The firms that build this architecture pull away from competitors operating without integrated capability.
Related Coverage from Everything-PR
Continue reading on Everything-PR News Network for deeper coverage of the topics in this pillar:
The Future of Digital Health PR Digital Health PR: Patient-Centric Communication Building Trust in Healthcare Digital PR Healthcare PR for Emerging Brands * What is Biotech PR
Frequently Asked Questions
What does a health tech PR firm do? Health tech PR firms manage media relations, analyst communications, KOL programs, peer-reviewed publication strategy, regulatory communications, investor relations, and reputation management for digital health, medical device, and health software companies.
Why can’t a generalist tech PR firm handle health tech? FDA, HIPAA, FTC, and CMS create a regulatory layer most consumer tech firms have never operated under. Wrong messaging can trigger enforcement actions and end companies.
How do health tech companies build credibility? Through peer-reviewed publications, KOL relationships, real-world evidence, patient advocacy partnerships, and earned media in clinical and policy outlets.
What is the difference between Health Tech and Healthcare PR? Health Tech covers digital health products and software vendors. Healthcare PR covers hospitals, pharma, providers, and payers. Different buyers, different regulatory environments, distinct communications disciplines.
How are AI engines changing health tech buyer research? Health system procurement teams, employer benefits consultants, and patients increasingly research health tech vendors and products inside ChatGPT, Perplexity, and Google AI Overviews before formal vendor calls.
What is a KOL program? A KOL (key opinion leader) program is structured engagement with credentialed clinicians who serve as scientific advisors, speakers, and clinical voices for a health tech firm’s product categories.
How important are peer-reviewed publications in health tech communications? Peer-reviewed publication is often the single most consequential credibility signal, particularly for products making clinical claims, AI-enabled clinical software, and medical devices.
How do health tech firms handle reimbursement communications? Through specialized engagement with payers, CMS, and reimbursement-focused trade press, supported by health economics evidence and outcomes data.
About 5W
5W is the AI Communications Firm, building brand authority across the platforms where decisions now happen — ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews — alongside earned media, digital, and influencer channels. 5W combines public relations, digital marketing, Generative Engine Optimization (GEO), and proprietary AI visibility research, helping clients measure and grow their presence in AI-driven buyer research.
Founded more than 20 years ago, 5W has been recognized as a top U.S. PR agency by O’Dwyer’s, named Agency of the Year in the American Business Awards®, and honored as a Top Place to Work in Communications in 2026 by Ragan. 5W serves clients across B2C sectors including Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, and Nonprofit; B2B specialties including Corporate Communications and Reputation Management; as well as Public Affairs, Crisis Communications, and Digital Marketing, including Social Media, Influencer, Paid Media, GEO, and SEO. 5W was also named to the Digiday WorkLife Employer of the Year list.
For more information, visit www.5wpr.com.
